Tamarly Intelligence
Tamarly Intelligence · The Wall

Filings, economic releases and risk events, as they happen

The latest 80 items from SEC EDGAR, government statistics, regulators and official risk feeds, newest first, each linked to its source. A free account adds news and builds your own Wall from the companies and countries you follow. Start free

27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Merck Sharp & Dohme LLC: Registered: phase 3 by Merck Sharp & Dohme LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Lumicell, Inc.: Registered: phase 3 by Lumicell, Inc.
Regulation · ClinicalTrials.gov
27 Oct 2026
Pfizer: Registered: phase 3 by Pfizer
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Daiichi Sankyo: Registered: phase 3 by Daiichi Sankyo
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Suzhou Suncadia Biopharmaceuticals Co., Ltd.: Registered: phase 3 by Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Regulation · ClinicalTrials.gov
27 Oct 2026
Otsuka Pharmaceutical Development & Commercialization, Inc.: Registered: phase 3 by Otsuka Pharmaceutical Development & Commercialization, Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Rapport Therapeutics Inc.: Registered: phase 3 by Rapport Therapeutics Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Novartis Pharmaceuticals: Registered: phase 3 by Novartis Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Regeneron Pharmaceuticals: Registered: phase 3 by Regeneron Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Pfizer: Registered: phase 3 by Pfizer
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Opus Genetics, Inc: Registered: phase 3 by Opus Genetics, Inc
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Armstrong World Industries Inc filed a 10-Q
Filing · SEC EDGAR · company page · USA
27 Oct 2026
Annexon, Inc.: Registered: phase 3 by Annexon, Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Lantheus Germany GmbH: Registered: phase 3 by Lantheus Germany GmbH
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Vivacelle Bio: Registered: phase 3 by Vivacelle Bio
Regulation · ClinicalTrials.gov
27 Oct 2026
Hazardous Materials: Harmonization With International Standards
Risk · US Federal Register · company page · USA
27 Oct 2026
Mattresses From Cambodia, China, Malaysia, Serbia, Thailand, Turkey, and Vietnam; Determinations
Risk · US Federal Register · company page · KHM
27 Oct 2026
Critical Material List; Addition of Helium
Risk · US Federal Register · company page · USA
27 Oct 2026
Bipartisan Safer Communities Act of 2022-Criteria for National Instant Criminal Background Check System (“NICS”) Background Checks of Firearm Handlers
Risk · US Federal Register · company page · USA
27 Oct 2026
Novartis Pharmaceuticals: Registered: phase 3 by Novartis Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Edesa Biotech Inc.: Registered: phase 2 3 by Edesa Biotech Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Merck Sharp & Dohme LLC: Registered: phase 3 by Merck Sharp & Dohme LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
UCB Biopharma SRL: Registered: phase 3 by UCB Biopharma SRL
Regulation · ClinicalTrials.gov
27 Oct 2026
Insmed Incorporated: Registered: phase 3 by Insmed Incorporated
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Arrowhead Pharmaceuticals: Registered: phase 3 by Arrowhead Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Pfizer: Registered: phase 3 by Pfizer
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
BeOne Medicines: Registered: phase 3 by BeOne Medicines
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Renaissance Pharma Ltd.: Registered: phase 2 3 by Renaissance Pharma Ltd.
Regulation · ClinicalTrials.gov
27 Oct 2026
Otsuka Pharmaceutical Development & Commercialization, Inc.: Registered: phase 3 by Otsuka Pharmaceutical Development & Commercialization, Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Samsung Bioepis Co., Ltd.: Registered: phase 3 by Samsung Bioepis Co., Ltd.
Regulation · ClinicalTrials.gov
27 Oct 2026
Pfizer: Registered: phase 3 by Pfizer
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Bristol-Myers Squibb: Registered: phase 3 by Bristol-Myers Squibb
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
AstraZeneca: Registered: phase 3 by AstraZeneca
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Jiangsu HengRui Medicine Co., Ltd.: Registered: phase 3 by Jiangsu HengRui Medicine Co., Ltd.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Arcus Biosciences, Inc.: Registered: phase 3 by Arcus Biosciences, Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Vericel Corporation: Registered: phase 3 by Vericel Corporation
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Grifols Therapeutics LLC: Registered: phase 3 by Grifols Therapeutics LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Daiichi Sankyo: Registered: phase 2 3 by Daiichi Sankyo
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Merck Sharp & Dohme LLC: Registered: phase 2 3 by Merck Sharp & Dohme LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
4D Molecular Therapeutics: Registered: phase 3 by 4D Molecular Therapeutics
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
UCB Biopharma SRL: Registered: phase 3 by UCB Biopharma SRL
Regulation · ClinicalTrials.gov
27 Oct 2026
UCB Biopharma SRL: Registered: phase 3 by UCB Biopharma SRL
Regulation · ClinicalTrials.gov
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Novartis Pharmaceuticals: Registered: phase 3 by Novartis Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Merck Sharp & Dohme LLC: Registered: phase 3 by Merck Sharp & Dohme LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Opus Genetics, Inc: Registered: phase 3 by Opus Genetics, Inc
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Merck Sharp & Dohme LLC: Registered: phase 3 by Merck Sharp & Dohme LLC
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eli Lilly and Company: Registered: phase 3 by Eli Lilly and Company
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Vertex Pharmaceuticals Incorporated: Registered: phase 2 3 by Vertex Pharmaceuticals Incorporated
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Regeneron Pharmaceuticals: Registered: phase 3 by Regeneron Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Waterstone Pharmaceutical (Wuhan) Co., LTD.: Registered: phase 3 by Waterstone Pharmaceutical (Wuhan) Co., LTD.
Regulation · ClinicalTrials.gov
27 Oct 2026
Cboe Clear U.S., LLC; Order Granting an Application, as Amended, for Temporary Registration as a Clearing Agency Under Section 17A of the Securities Exchange Act of 1934
Regulation · Securities and Exchange Commission
27 Oct 2026
Kite, A Gilead Company: Registered: phase 3 by Kite, A Gilead Company
Regulation · ClinicalTrials.gov
27 Oct 2026
Neurotech Pharmaceuticals: Registered: phase 3 by Neurotech Pharmaceuticals
Regulation · ClinicalTrials.gov
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Agios Pharmaceuticals, Inc.: Registered: phase 2 3 by Agios Pharmaceuticals, Inc.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Hoffmann-La Roche: Registered: phase 3 by Hoffmann-La Roche
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Qilu Pharmaceutical Co., Ltd.: Registered: phase 3 by Qilu Pharmaceutical Co., Ltd.
Regulation · ClinicalTrials.gov
27 Oct 2026
Eurofarma Laboratorios S.A.: Registered: phase 3 by Eurofarma Laboratorios S.A.
Regulation · ClinicalTrials.gov
27 Oct 2026
Regeneron Pharmaceuticals: Registered: phase 3 by Regeneron Pharmaceuticals
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
AstraZeneca: Registered: phase 3 by AstraZeneca
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Bristol-Myers Squibb: Registered: phase 3 by Bristol-Myers Squibb
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Jiangsu HengRui Medicine Co., Ltd.: Registered: phase 3 by Jiangsu HengRui Medicine Co., Ltd.
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Multitude Therapeutics Inc.: Registered: phase 2 3 by Multitude Therapeutics Inc.
Regulation · ClinicalTrials.gov
27 Oct 2026
Shionogi: Registered: phase 3 by Shionogi
Regulation · ClinicalTrials.gov · company page
27 Oct 2026
Pfizer: Registered: phase 3 by Pfizer
Regulation · ClinicalTrials.gov · company page · USA
27 Oct 2026
Peptilogics: Registered: phase 2 3 by Peptilogics
Regulation · ClinicalTrials.gov
27 Oct 2026
Suzhou Suncadia Biopharmaceuticals Co., Ltd.: Registered: phase 3 by Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Regulation · ClinicalTrials.gov
27 Oct 2026
Bristol-Myers Squibb: Registered: phase 3 by Bristol-Myers Squibb
Regulation · ClinicalTrials.gov · company page

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.